Filing Details
- Accession Number:
- 0001127602-23-018783
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-15 16:37:27
- Reporting Period:
- 2023-06-13
- Accepted Time:
- 2023-06-15 16:37:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882796 | Biocryst Pharmaceuticals Inc | BCRX | Biological Products, (No Disgnostic Substances) (2836) | 621413174 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1718020 | Machelle Sanders | 4505 Emperor Blvd. Suite 200 Durham NC 27703 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-06-13 | 16,745 | $0.00 | 29,611 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2023-06-15 | 4,000 | $7.98 | 25,611 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Automatic Stock Option Grant | Acquisiton | 2023-06-13 | 39,072 | $0.00 | 39,072 | $8.18 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 39,072 | 2024-06-13 | 2033-06-13 | No | 4 | A | Direct |
Footnotes
- Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
- Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.
Billionaire Hedge Funds
